Skip to main content

Table 6 Comparative analysis on costs per QALY

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

  POLYMOD Roxanne CoRoVa
Health-care perspective    
Afr $ 265a $ 188-367b $ 233-440 b
Sear $ 358a $ 257-503b $ 308-591 b
Amr $ 307a $ 200-652b $ 336-862 b
Eur € 57,897 € 50,999 € 56,656
Societal perspective    
Afr $ 260a $ 185-364 b $ 231-438 b
Sear $ 328a $ 241-487 b $ 293-577 b
Amr $ 196a $ 143-595 b $ 282-809 b
Eur € 49,427 € 40,041 € 44,263
  1. a. based on future reduction of vaccine prices from $7.5 to $4; b. Range given for previous upper and lower vaccine prices